Sermorelin Acetate and Ipamorelin Injection Recall – Sterility Assurance
Talon Compounding Pharmacy is recalling Sermorelin Acetate 6mg/Ipamorelin 6mg lyophilized vials due to lack of assurance of sterility. The affected product was distributed across the United States, Washington, D.C., and Puerto Rico.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II drug recall involving lack of sterility assurance for an injectable product. Non-sterile injections present serious risk of infection and systemic complications. Although no specific illnesses or injuries are reported in the source, the Class II designation and the fundamental sterility defect in a parenteral pharmaceutical product meet the criteria for a Severe rating.
Plain-English summary
Talon Compounding Pharmacy (Vita Pharmacy, LLC) is recalling Sermorelin Acetate 6mg/Ipamorelin 6mg lyophilized vials, 6mg/6mg per vial, distributed as a prescription-only product from its facility in San Antonio, Texas. The recall is being conducted because the manufacturer cannot provide assurance of sterility for the affected lots.
The affected product consists of 11 vials total from three lots with the following codes: Lot 06022021:03 with Beyond Use Date (BUD) 11/29/2021; Lot 08102021:27 with BUD 11/30/2021; and Lot 05212021:84 with BUD 11/17/2021. Distribution of the recalled product extended throughout the United States, including Washington, D.C., and Puerto Rico.
Consumers or healthcare providers who have received this product should not use it. Patients currently using these vials should contact their healthcare provider or pharmacist immediately for guidance on obtaining a replacement product or alternative treatment.
The recalled product
- Product
- SERMORELIN ACETATE 6MG/IPAMORELIN 6MG - LYOPHILIZED 6MG/6MG VIAL, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
- Affected units
- 11
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot: 06022021:03 BUD: 11/29/2021
- 08102021:27 BUD: 11/30/2021
- 05212021:84 BUD: 11/17/2021
Distribution
Part of a larger recall action
This product is one of 130 recalled by Vita Pharmacy, LLC dba Talon Compounding Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 130 products in this recall →Related recalls
Same manufacturer · Vita Pharmacy, LLC dba Talon Compounding Pharmacy
See all →- HighInjectable testosterone and dutasteride product recall for sterility assurance failure
FDA (Drugs) · 2021-11-17
- HighIC B Complex Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-11-17
- SevereTRI-MIX Injectable by Talon Compounding Pharmacy Recalled for Sterility Assurance
FDA (Drugs) · 2021-11-17
- SevereInjectable Steroid Combination Product Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-11-17
- HighTestosterone Bi-Blend Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-11-17
Same hazard · sterility assurance
See all →- HighArrowhead DE LLC Recalls Arrow-LOK Implants Due to Sterility Assurance Concerns
FDA (Devices) · 2026-08-26
- SevereChloraPrep One-Step Applicators Recalled for Potential Packaging Seal Defects
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15
- SevereChloraPrep One-Step Applicators Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2026-07-08
- SevereArrow drainage and thoracentesis kits contain recalled supplier drugs
FDA (Devices) · 2026-06-24